CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.

Tomassi, Stefano et al.·Journal of medicinal chemistry·2022·
RPEP-065432022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Compound 5 showed remarkable functional selectivity toward the hMC1R receptor.

Key Numbers

How They Did This

The study utilized a Chemical Linkage of Peptide onto Scaffolds strategy to modify melanotan II and assessed binding affinities through molecular dynamics simulations.

Why This Research Matters

Improving selectivity of receptor agonists can lead to better therapeutic options with fewer side effects. This research contributes to the development of targeted treatments for conditions influenced by melanocortin receptors.

What This Study Doesn't Tell Us

The study primarily focuses on in vitro findings, which may not fully translate to in vivo results or human applications.

Trust & Context

Original Title:
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.
Published In:
Journal of medicinal chemistry, 65(5), 4007-4017 (2022)
Database ID:
RPEP-06543

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06543·https://rethinkpeptides.com/research/RPEP-06543

APA

Tomassi, Stefano; Dimmito, Marilisa Pia; Cai, Minying; D'Aniello, Antonia; Del Bene, Alessandra; Messere, Anna; Liu, Zekun; Zhu, Tingyi; Hruby, Victor J; Stefanucci, Azzurra; Cosconati, Sandro; Mollica, Adriano; Di Maro, Salvatore. (2022). CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.. Journal of medicinal chemistry, 65(5), 4007-4017. https://doi.org/10.1021/acs.jmedchem.1c01848

MLA

Tomassi, Stefano, et al. "CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists.." Journal of medicinal chemistry, 2022. https://doi.org/10.1021/acs.jmedchem.1c01848

RethinkPeptides

RethinkPeptides Research Database. "CLIPSing Melanotan-II to Discover Multiple Functionally Sele..." RPEP-06543. Retrieved from https://rethinkpeptides.com/research/tomassi-2022-clipsing-melanotanii-to-discover

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.